NAFLD fibrosis score: Is it ready for wider use in clinical practice and for clinical trials?

Gastroenterology

Volumn 145, Issue 4, 2013, Pages 717-719

  Gawrieh, Samer ^a,b   Chalasani, Naga ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CAFFEINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFERRIN;

ALCOHOL CONSUMPTION; BODY MASS; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); HUMAN; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WAIST CIRCUMFERENCE;

EID: 84884387757     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.08.025     Document Type: Editorial

References (16)

1. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
2. D.L. White, F. Kanwal, and H.B. El-Serag Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review Clin Gastroenterol Hepatol 10 2012 1342 1359
3. G. Targher, C.P. Day, and E. Bonora Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 2010 1341 1350
4. N. Rafiq, C. Bai, and Y. Fang Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 2009 234 238
5. J.P. Ong, A. Pitts, and Z.M. Younossi Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease J Hepatol 49 2008 608 612
6. N. Chalasani, Z. Younossi, and J.E. Lavine The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 2012 1592 1609
7. M.V. Machado, and H. Cortez-Pinto Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal J Hepatol 58 2013 1007 1019
8. P. Angulo, J.M. Hui, and G. Marchesini The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
9. S.A. Harrison, D. Oliver, and H.L. Arnold Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut 57 2008 1441 1447
10. C.T. Wai, J.K. Greenson, and R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
11. R.K. Sterling, E. Lissen, and N. Clumeck Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV co-infection Hepatology 43 2006 1317 1325
12. A.G. Shah, A. Lydecker, and K. Murray Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 7 2009 1104 1112
13. P. Angulo, E. Bugianesi, and E.S. Bjornsson Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 145 2013 782 789
14. Z.M. Younossi, M. Stepanova, and N. Rafiq Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality Hepatology 53 2011 1874 1882
15. G. Musso, R. Gambino, and M. Cassader Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Ann Med 43 2011 617 649
16. D. Kim, W.R. Kim, and H.J. Kim Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States Hepatology 57 2013 1357 1365